Vaxart, Inc. (VXRT): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$34.76M
As of 2023-12-31
+24.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $34.76M | -21.0% | 2024-03-14, Balance as of period end |
| 2022-12-31 | $44.01M | -69.4% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $143.75M | n/a | 2023-03-15, Balance as of period end |
| No annual figure between 2018-12-31 and 2021-12-31. | |||
| 2018-12-31 | $11.51M | +632.4% | 2019-02-06, Balance as of period end |
| 2017-12-31 | $1.57M | n/a | 2019-02-06, Balance as of period end |
| 2017-06-30 | $17.70M | -64.4% | 2017-09-01, Balance as of period end |
| 2016-06-30 | $49.70M | +11.2% | 2017-09-01, Balance as of period end |
| 2015-06-30 | $44.70M | -45.3% | 2016-09-13, Balance as of period end |
| 2014-06-30 | $81.70M | +22.3% | 2016-09-13, Balance as of period end |
| 2013-06-30 | $66.80M | +24.2% | 2015-09-11, Balance as of period end |
| 2012-06-30 | $53.80M | n/a | 2014-09-30, Balance as of period end |
| 2011-12-31 | $94.31M | n/a | 2012-03-14, Balance as of period end |
| 2011-06-30 | $74.20M | n/a | 2013-09-27, Balance as of period end |
| 2010-12-25 | $53.56M | -10.0% | 2012-03-14, Balance as of period end |
| 2009-12-26 | $59.51M | n/a | 2012-03-14, Balance as of period end |